CelltiX+

Next-Generation Exosome Technology for Advanced Regenerative, Immune, Joint & Aesthetic Research

CelltiX+ is an advanced exosome-based product line by Cell Tissue Group, developed to support targeted research in cellular communication, regenerative signalling, immune-related pathways, joint-support models, and aesthetic rejuvenation studies.

Building on the foundation of CelltiX, the CelltiX+ range introduces specialised formulations designed for different biological focus areas. Each variant is developed with a distinct functional direction, allowing researchers and professional users to select the most relevant formulation according to the intended focus.

• CelltiX+ Thymus
  • Immune Signalling & Immune Support Research
  • CelltiX+ Thymus is designed for research involving immune-related cellular communication. It features an advanced thymus-focused exosome concept associated with immune signalling, cellular education pathways, and immune modulation research.
  • This variant is suitable for studies exploring:
    • Immune system signalling
    • Immune balance research
    • Cellular education pathways
    • Ageing-related immune function
    • Inflammation and immune-response models
• CelltiX+ Hyaluronic Acid
  • Knee & Joint Support Research
  • CelltiX+ Hyaluronic Acid is formulated for knee and joint-focused research. Hyaluronic Acid is widely recognised for its role in hydration, lubrication, cushioning, and extracellular matrix support.
  • This variant is suitable for studies exploring:
  • Joint comfort and mobility-related models
  • Cartilage and connective tissue support research
  • Lubrication and cushioning mechanisms
  • Knee-focused regenerative signalling
  • Ageing-related joint function studies
• CelltiX+ Hyaluronic Acid with Collagen
  • Face & Skin Rejuvenation Research
  • CelltiX+ Hyaluronic Acid with Collagen is developed for face and aesthetic-focused research. This variant combines the hydration-supporting properties of Hyaluronic Acid with the structural support role of Collagen, making it relevant for skin quality, firmness, elasticity, and rejuvenation-related studies.
  • This variant is suitable for studies exploring:
    • Skin hydration and moisture retention
    • Skin firmness and elasticity support
    • Facial rejuvenation research
    • Collagen matrix support
    • Ageing-related skin appearance models
      

WHY CELLTIX+ IS DIFFERENT?

Most exosome products are developed as general single-focus formulations. CelltiX+ is designed as a targeted exosome-based product family built on the foundation of Umbilical Cord MSC-derived exosomes, with each variant enhanced by selected functional components according to its intended research focus.

Umbilical Cord MSC-derived exosomes form the core foundation of the CelltiX+ range. They are known for their role in cellular repair signalling, tissue regeneration pathways, and intercellular communication, making them highly relevant for regenerative and cellular function research.

To create a more targeted product family, CelltiX+ is available in three specialised variants:

• CelltiX+ Thymus
  • Combines Umbilical Cord MSC-derived exosomes with iPSC-derived thymus cell exosomes. This variant is associated with regenerative signalling, immune system signalling, cellular education pathways, and immune modulation research.
• CelltiX+ Hyaluronic Acid
  • Combines Umbilical Cord MSC-derived exosomes with Hyaluronic Acid. This variant is designed for knee and joint-focused research, where Hyaluronic Acid is commonly associated with hydration, lubrication, cushioning, and extracellular matrix support.
• CelltiX+ Hyaluronic Acid with Collagen
  • Combines Umbilical Cord MSC-derived exosomes with Hyaluronic Acid and Collagen. This variant is designed for face and aesthetic-focused research, where Hyaluronic Acid supports hydration-related studies while Collagen supports structural matrix, firmness, elasticity, and skin-quality research.

By combining Umbilical Cord MSC-derived exosomes with targeted functional components, CelltiX+ is designed to go beyond conventional general-purpose exosome preparations. Each variant provides a clearer research direction across immune, joint, and aesthetic applications while maintaining the same core regenerative exosome foundation.

POTENTIAL RESEARCH FOCUS AREAS

CelltiX+ is suitable for research exploring cellular communication, regenerative signalling, and targeted functional pathways across immune, joint, and aesthetic-related models.

Built on the foundation of Umbilical Cord MSC-derived exosomes, the CelltiX+ range may support research involving:

• Tissue regeneration and cellular recovery mechanisms
  • Exploring how exosome-based signalling may contribute to cellular repair, recovery response, and tissue-support pathways.
• Intercellular communication and regenerative signalling
  • Studying how extracellular vesicle signalling may influence communication between cells in regenerative and functional research models.
• Immune system signalling and immune modulation pathways
  • Particularly relevant for CelltiX+ Thymus, focusing on immune-related cellular communication, immune balance, and cellular education pathways.
• Knee, joint, and connective tissue support models
  • Particularly relevant for CelltiX+ Hyaluronic Acid, exploring hydration, lubrication, cushioning, extracellular matrix support, and mobility-related research.
• Skin quality, firmness, and aesthetic rejuvenation studies
  • Particularly relevant for CelltiX+ Hyaluronic Acid with Collagen, focusing on hydration support, collagen matrix research, elasticity, firmness, and ageing-related skin appearance models.
• Ageing-related cellular function studies
  • Exploring cellular resilience, regenerative response, immune ageing, joint ageing, and skin ageing-related research pathways.
• Inflammation and cellular balance research
  • Studying how targeted exosome-based formulations may relate to inflammation-response models, immune balance, and tissue-support environments.
• Cellular resilience and repair signalling models
  • Investigating how cells respond to stress, ageing, environmental changes, and recovery-related biological signals.

SAFETY AND QUALITY

CelltiX+ is developed with a strong emphasis on source control, formulation consistency, and research-use suitability. Each variant is designed to maintain a reliable exosome-based foundation while incorporating targeted functional components according to its intended research focus.

• Controlled and traceable biological source
  • Built on Umbilical Cord MSC-derived exosomes sourced through controlled and traceable human cell-based processes.
• Targeted variant-specific formulation
  • Each CelltiX+ variant is formulated with selected functional components, such as iPSC-derived thymus cell exosomes, Hyaluronic Acid, or Hyaluronic Acid with Collagen, depending on the intended research direction.
• Standardised processing approach
  • Processed using quality-driven protocols to support consistency, reliability, and controlled product handling.
• Non-living, cell-free formulation
  • Designed as an exosome-based, cell-free preparation without living cells.
• Research-use suitability
  • Developed for laboratory, investigational, and professional research applications.
• Quality-focused product design
  • Formulated to support targeted research across regenerative signalling, immune-related pathways, joint-support models, and aesthetic rejuvenation studies.

IMPORTANT NOTICE
For research use only.
CelltiX+ is not intended for human use, diagnosis, treatment, or prevention of any disease. All information provided is for scientific, educational, and research purposes only.